RSV in Challenging Times: Impact and Implications of the Global COVID-19 Pandemic

Monday 9 May, 9.45 – 11.15
Athens time (CET+1) | A. Trianti Hall

Managing Invasive Meningococcal Disease (IMD) in Children – The Current Impact and Future Preventative Perspectives

Tuesday 10 May, 9.45 – 11.15
Athens time (CET+1) | A. Trianti Hall

Immunization as a Framework for Improving Adolescent Health

Friday 13 May, 14.15 – 15.45
Athens time (CET+1) | A. Trianti Hall

RSV in Challenging Times: Impact and Implications of the Global COVID-19 Pandemic

Monday 9 May, 9.45 – 11.15
Athens time (CET+1) | A. Trianti Hall

Opening remarks

Maria Tsolia, MD, University of Athens, Greece

A closer look at the evolving epidemiology of RSV due to COVID

Fernanda Rodrigues, MD, PhD, Centro Hospitalar e Universitário de Coimbra, Portugal

The extended reach of the substantial RSV burden of disease

Chiara Azzari, MD, PhD, University of Florence, Italy

Understanding neutralizing antibody protection through RSV virology and pathogenesis

Ultan Power, PhD, Queen’s University Belfast, Northern Ireland, United Kingdom

Audience Q&A

All

Summary and closing remarks

Maria Tsolia, MD, University of Athens, Greece

Managing Invasive Meningococcal Disease (IMD) in Children – The Current Impact and Future Preventative Perspectives

Tuesday 10 May, 9.45 – 11.15
Athens time (CET+1) | A. Trianti Hall

Welcome and introduction

Georgina Tzanakaki, MD, Hellenic National School of Publich Health, Greece

Keeping our guard up against childhood IMD

Out of time – Episode 5 (Pre-recorded)

Round table discussion and expert perspectives on challenges in childhood IMD epidemiology, impact of the COVID-19 pandemic, vaccination trends and unmet needs

Georgina Tzanakaki, MD, Hellenic National School of Publich Health, Greece
Ener Cagri Dinleyici, MD, Eskisehir Osmangazi University Faculty of Medicine, Turkey
Elena Moya, Confederation of Meningitis Organisations

Current progress and gaps in childhood vaccination to prevent IMD

Georgina Tzanakaki, MD, Hellenic National School of Publich Health, Greece

The continuing childhood burden of IMD: the patient and family perspectives

Elena Moya, Confederation of Meningitis Organisations

The MenACYW vaccine armamentarium against IMD in paediatric populations

Ener Cagri Dinleyici, MD, Eskisehir Osmangazi University Faculty of Medicine, Turkey

Discussion and Q&A

All

Immunization as a Framework for Improving Adolescent Health

Friday 13 May, 14.15 – 15.45
Athens time (CET+1) | A. Trianti Hall

Introduction to global adolescent immunization platforms

Jonathan Klein, MD, MPH, University of Illinois Chicago, US

The current portrait of adolescent immunization

Catherine Weil-Olivier, MD, Paris VII University, France

Factors impacting the landscape of adolescent health

Nuray Kanbur, MD, FSAHM, University of Ottawa, Canada

Developing an approach for adolescent care: Health supervision and anticipatory guidance

Asha Pemberton, MBBS, DM (PAED), The University of the West Indies, Trinidad and Tobago

Setting the scene for global assessments of adolescents’ situations and needs

Pierre-André Michaud, MD, Faculty of Biology & Medicine of Lausanne, Switzerland

Panel discussion and Q&A

All